Bedaquiline-containing regimens in patients with pulmonary multidrug-resistant tuberculosis in China: focus on the safety

BACKGROUND: World Health Organization recommends countries introducing new drug and short treatment regimen for drug resistant tuberculosis (DR-TB) should develop and implement a system for active pharmacovigilance that allows for detection, reporting and management of adverse events. The aim of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Jing-Tao, Du, Juan, Wu, Gui-Hui, Pei, Yi, Gao, Meng-Qiu, Martinez, Leonardo, Fan, Lin, Chen, Wei, Xie, Li, Chen, Yu, Wang, Hua, Jin, Long, Li, Guo-Bao, Zong, Pei-Lan, Xiong, Yu, Wu, Qian-Hong, Li, Ming-Wu, Yan, Xiao-Feng, Miao, Yan-Fang, Cai, Qing-Shan, Li, Xin-Jie, Bai, Da-Peng, Geng, Shu-Jun, Yang, Guo-Li, Tang, Pei-Jun, Zeng, Yi, Chen, Xiao-Hong, Li, Tong-Xia, Cai, Cui, Zhou, Yun, Zhuo, Ma, Wang, Jian-Yun, Guan, Wen-Long, Xu, Lin, Shi, Ji-Chan, Shu, Wei, Cheng, Li-Li, Teng, Fei, Ning, Yu-Jia, Xie, Shi-Heng, Sun, Yu-Xian, Zhang, Li-Jie, Liu, Yu-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7977294/
https://www.ncbi.nlm.nih.gov/pubmed/33736710
http://dx.doi.org/10.1186/s40249-021-00819-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7977294/
https://www.ncbi.nlm.nih.gov/pubmed/33736710
http://dx.doi.org/10.1186/s40249-021-00819-2

Ejemplares similares